(Q84742919)

English

Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice

scientific article published on 11 August 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21833001%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21833001%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

ventricular remodeling

1 reference

based on heuristic

inferred from title

author name string

Yasutomi Higashikuni

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21833001%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Minoru Takaoka

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21833001%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Hiroshi Iwata

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21833001%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Kimie Tanaka

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21833001%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Yasunobu Hirata

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21833001%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Ryozo Nagai

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21833001%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Masataka Sata

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21833001%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

11 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21833001%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Hypertension Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21833001%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21833001%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21833001%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

62-69

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21833001%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

https://scigraph.springernature.com/pub.10.1038/hr.2011.136

0 references

Cardiac resuscitation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracardiac renin-angiotensin system and myocardial repair/remodeling following infarction

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Aliskiren: the first renin inhibitor for clinical treatment

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Valvular interstitial cells express angiotensinogen and cathepsin D, and generate angiotensin peptides

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Tonin in rat heart with experimental hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

The ATP-Binding Cassette Transporter BCRP1/ABCG2 Plays a Pivotal Role in Cardiac Repair After Myocardial Infarction Via Modulation of Microvascular Endothelial Cell Survival and Function

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamic observation of mechanically-injured mouse femoral artery reveals an antiinflammatory effect of renin inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

A synthetic small molecule, ONO-1301, enhances endogenous growth factor expression and augments angiogenesis in the ischaemic heart

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Myocardial repair/remodelling following infarction: roles of local factors

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidative stress and left ventricular remodelling after myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidative stress in the infarcted heart: role of de novo angiotensin II production

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

NADPH oxidases in the kidney

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Telmisartan, ramipril, or both in patients at high risk for vascular events

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysi

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Aliskiren combined with losartan in type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical use of angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.136

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/HR.2011.136

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21833001%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21833001%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84742919&oldid=1517833166"